The US biopharmaceutical industry faces relentless disruption. America still leads the world in high-risk drug development, and revolutionary treatments may shape a new era of healthcare. But the path from innovation to access is beset by uncertainty around policy, regulation and investment. Stay informed and connected by attending the US Pharma and Biotech Summit 2026. Organized by FT Live in collaboration with Endpoints News, the event will bring together top executives, investors and experts
Thursday, May 14, 2026
New York, USA
From USD 229 - 2849
350 expected
The US biopharmaceutical industry faces relentless disruption. America still leads the world in high-risk drug development, and revolutionary treatments may shape a new era of healthcare. But the path from innovation to access is beset by uncertainty around policy, regulation and investment. Stay informed and connected by attending the US Pharma and Biotech Summit 2026. Organized by FT Live in collaboration with Endpoints News, the event will bring together top executives, investors and experts
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox